The Kaiser study found that co-expression of RORγt and T-bet in CD4+ cells was higher in the BAL of patients with Löfgren syndrome as compared to non-Löfgren sarcoidosis, suggesting that co-expression predicted a more favorable phenotype. Here, CD4 is linked to Löfgren’s syndrome.